Shanghai Creation Investment
Venture capitalShanghai · Late Stage
Investment thesis
ChuangRui invests predominantly in China's healthcare and medical technology sector. Its portfolio spans domestic manufacturers of surgical microscopes and endoscopes, orthopedic implants, in-vitro diagnostics equipment and reagents, precision oncology and molecular diagnostics platforms, CT/PET-CT imaging systems, cardiovascular AI diagnostics, and innovative antibody drugs. The firm supports companies developing homegrown, high-tech medical devices and equipment, several of which have achieved national recognition such as 'little giant' status. It also works with a network of state-backed and regional investment partners across China.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 1 of 15 portfolio companiesAI & Machine Learning ×1Digital Health ×1Healthtech ×1Medical Devices ×1
Investments · 15 tracked
founders shown can be your intro pathIsraeli developer of the world's first single-use 360-degree painless colonoscope, FDA-cleared.
Surgical Theater develops an XR visualization platform that helps surgeons plan and execute complex procedures by allowing them to explore patient anatomy in three-dimensional detail.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsFoothill VenturesHTC
Chinese oncology precision diagnostics and treatment platform.
Leading Chinese precision medicine solutions provider, founded 2017, part of the Simcere pharmaceutical group.
Top domestic provider of customized IVD equipment R&D and manufacturing, founded 2005.
Zhejiang high-tech company founded 1998 specializing in endoscopic minimally invasive medical devices.
One of China's most innovative antibody drug companies, founded 2012 by a returnee expert team.
First Chinese company approved to produce and sell a standardized sublingual desensitization drug for dust mite allergy.
Medical CT, PET and PET-CT developer with China's first fully domestically owned SiPM-based PET technology.
One of China's earliest rigid medical endoscope R&D and manufacturing companies, dating to the 1980s.
One of China's leading orthopedic implant/consumables providers, founded 1994; a national high-tech enterprise.
Hangzhou-based company with a leading non-invasive FFR cardiovascular AI diagnostic platform.
Shanghai IVD company founded 2000 with one of the most complete product lines in reagents and instruments.
CT detector manufacturer; China's first medical spiral CT detector project, based in Changzhou.
Leading domestic surgical microscope manufacturer, founded 2001; largest market share among domestic makers in China.
Frequently asked questions
- How many investments has Shanghai Creation Investment made?
- Shanghai Creation Investment has 15 tracked investments.
- What stage does Shanghai Creation Investment invest at?
- Shanghai Creation Investment invests at the Late Stage stage.
- What sectors does Shanghai Creation Investment focus on?
- Shanghai Creation Investment focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Shanghai Creation Investment located?
- Shanghai Creation Investment is headquartered in Shanghai, CN.
Similar investors
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Healthcare Venture Partners invests in innovative mid-to-late stage venture companies across the healthcare and life sciences industry, with particular emphasis on companies employing advanced technologies.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.